Greenphire Appoints Senior Director of Business Development in Europe
News Oct 10, 2013
Based in London, Alex will be responsible for developing market awareness of Greenphire's solutions and will lead the company's overall business development strategy in Europe. He joins Greenphire having previously served as Global Account Manager at Phase Forward (now Oracle), where he was charged with driving worldwide sales strategies. Previous to this role, he worked for G.D. Searle prior to its acquisition by Pfizer.
"Having admired Greenphire's achievements in the clinical payment technology field, its innovative nature and dynamic management team, I am delighted to have been chosen to lead the next stage of the company's development in Europe", comments Alex Livingstone. "I am excited to join a brand where innovation is valued and the desire to change things for the better is at the core of its strategy."
Commenting on the new appointment, Greenphire CEO Sam Whitaker said, "Alex's extensive experience in the industry will be a tremendous asset to Greenphire at a time when we are developing quickly as a business. He will play a key role in capturing commercial opportunities in key markets across Europe and I am confident Alex will be a strong asset to Greenphire and our clients alike."
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE